Synthesis and pharmacokinetic characterization of a pH-sensitive polyethylene glycol ginsenoside CK (PEG-CK) conjugate

References

• Choi KT. Botanical characteristics, pharmacological effects and medicinal components of Korean Panax ginseng C. A. Meyer. Acta Pharmacol. Sin. 2008;29:1109–1118.10.1111/aphs.2008.29.issue-9
   PubMed Web of Science ®Google Scholar
• Sathiyamoorthy S, In JG, Gayathri S, Kim YJ, Yang DC. Generation and gene ontology based analysis of expressed sequence tags (EST) from a Panax ginseng C. A. Meyer roots. Mol. Biol. Rep. 2010;37:3465–3472.10.1007/s11033-009-9938-z
   PubMed Web of Science ®Google Scholar
• Yang L, Liu Y, Liu CX. Metabolism and pharmacokinetics of ginsenosides. J. Pharmacokinet. Pharmacodyn. 2006;6:103–120.
   Google Scholar
• Akao T, Kida H, Kanaoka M, Hattori M, Kobashi K. Intestinal bacterial hydrolysis is required for the appearance of compound K in rat plasma after oral administration of ginsenoside Rb1 from Panax ginseng. J. Pharm. Pharmacol. 1998;50:1155–1160.10.1111/jphp.1998.50.issue-10
   PubMed Web of Science ®Google Scholar
• Hasegawa H, Sung JH, Matsumiya S, Uchiyama M. Main ginseng saponin metabolites formed by intestinal bacteria. Planta Med. 1996;62:453–457.10.1055/s-2006-957938
   PubMed Web of Science ®Google Scholar
• Kim DY, Park MW, Yuan HD, Lee HJ, Kim SH, Chung SH. Compound K induces apoptosis via CAMK-IV/AMPK pathways in HT-29 colon cancer cells. J. Agric. Food Chem. 2009;57:10573–10578.10.1021/jf902700h
   PubMed Web of Science ®Google Scholar
• Zhang B, Zhu XM, Hu JN, Ye H, Luo T, Liu XR., Li HY, Li W, Zheng YN, Deng ZY. Absorption mechanism of ginsenoside compound K and its butyl and octyl ester prodrugs in Caco-2 cells. J. Agric. Food Chem. 2012;60:10278–10284.10.1021/jf303160y
   PubMed Web of Science ®Google Scholar
• Sathishkumar N, Sathiyamoorthy S, Ramya M, Yang DU, Lee HN, Yang DC. Molecular docking studies of anti-apoptotic BCL-2, BCL-XL, and MCL-1 proteins with ginsenosides from Panax ginseng. J. Enzyme Inhib. Med. Chem. 2012;27:685–692.10.3109/14756366.2011.608663
   PubMed Web of Science ®Google Scholar
• Knop K, Hoogenboom R, Fischer D, Schubert US. Poly (ethylene glycol) in drug delivery: pros and cons as well as potential alternatives. Angew. Chem. Int. Ed. Engl. 2010;49:6288–6308.10.1002/anie.200902672
   PubMed Web of Science ®Google Scholar
• Sun Y, Yan X, Yuan T, Liang J, Fan Y, Gu Z, Zhang X. Disassemblable micelles based on reduction-degradable amphiphilic graft copolymers for intracellular delivery of doxorubicin. Biomaterials. 2010;31:7124–7131.10.1016/j.biomaterials.2010.06.011
   PubMed Web of Science ®Google Scholar
• Lee H, Lee K, Park TG. Hyaluronic acid-paclitaxel conjugate micelles: synthesis, characterization, and antitumor activity. Bioconjug. Chem. 2008;19:1319–1325.10.1021/bc8000485
   PubMed Web of Science ®Google Scholar
• Min KH, Lee HJ, Kim K, Kwon IC, Jeong SY, Lee SC. The tumor accumulation and therapeutic efficacy of doxorubicin carried in calcium phosphate-reinforced polymer nanoparticles. Biomaterials. 2012;33:5788–5797.10.1016/j.biomaterials.2012.04.057
   PubMed Web of Science ®Google Scholar
• Thambi T, Yoon HY, Kim K, Kwon IC, Yoo CK, Park JH. Bioreducible block copolymers based on poly(ethylene glycol) and poly(gamma-benzyl L-glutamate) for intracellular delivery of camptothecin. Bioconjug. Chem. 2011;22:1924–1931.10.1021/bc2000963
   PubMed Web of Science ®Google Scholar
• Thambi T, Deepagan VG, Yoo CK, Park JH. Synthesis and physicochemical characterization of amphiphilic block copolymers bearing acid-sensitive orthoester linkage as the drug carrier. Polymer. 2011;52:4753–4759.10.1016/j.polymer.2011.08.024
   Web of Science ®Google Scholar
• Thambi T, Deepagan VG, Ko H, Lee DS, Park JH. Bioreducible polymersomes for intracellular dual-drug delivery. J. Mater. Chem. 2012;22:22028–22036.10.1039/c2jm34546c
   Web of Science ®Google Scholar
• Li J, Wang Y, Yang C, Wang P, Oelschlager DK, Zheng Y, Tian DA, Grizzle WE, Buchsbaum DJ, Wan M. Polyethylene glycosylated curcumin conjugate inhibits pancreatic cancer cell growth through inactivation of Jab1. Mol. Pharmacol. 2009;76:81–90.10.1124/mol.109.054551
   PubMed Web of Science ®Google Scholar
• Scott LC, Yao JC, Benson AB 3rd, Thomas AL, Falk S, Mena RR, Picus J, Wright J, Mulcahy MF, Ajani JA, Evans TR. A phase II study of pegylated-camptothecin (pegamotecan) in the treatment of locally advanced and metastatic gastric and gastro-oesophageal junction adenocarcinoma. Cancer Chemother. Pharmacol. 2009;63:363–370.10.1007/s00280-008-0746-2
   PubMed Web of Science ®Google Scholar
• Park SY, Han DK, Kim SC. Synthesis and Characterization of Star-Shaped PLLA-PEO Block Copolymers with Temperature-Sensitive Sol-Gel Transition Behavior. Macromolecules. 2001;34:8821–8824.10.1021/ma010789d
   Web of Science ®Google Scholar